We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Blood Test Could Identify Diabetes Decades Before It Develops

By LabMedica International staff writers
Posted on 22 Jul 2015
Print article
The Light Cycler 480 II real-time polymerase chain reaction (PCR) amplification and detection instrument
The Light Cycler 480 II real-time polymerase chain reaction (PCR) amplification and detection instrument (Photo courtesy of Roche Diagnostics)
A small molecule circulates in the blood of people who are in the early stages of type 1 diabetes and a simple blood test could detect this biological marker years, maybe decades, before symptoms develop.

Micro ribonucleic acids (miRNAs) carry snippets of genetic information across cells, and are regularly released into the blood stream and in diabetes the levels of some of these miRNAs in the circulation changes, and a blood test could detect these variations.

An international team of scientists, led by those at the Imperial College London (UK), have been able to identify a miRNA that is linked to the pancreas. They first used a murine model to establish the techniques and then recruited individuals diagnosed with diabetes who were less than 45 years of age. The subjects studied included 45 with the genetic mutation HNF1α-MODY3, 38 with type 1 diabetes (T1D) and 58 with type 2 diabetes (T2D). There were 51 controls who were normoglycemic individuals aged 30 to 50 years.

RNA was reverse transcribed using a High Capacity cDNA Reverse Transcription kit and miRNA levels were measured using the TaqMan microRNA Assays (Applied Biosystems; Waltham, MA, USA). Quantitative polymerase chain reaction (PCR) was performed by Roche 384 real-time PCR machine and using Light Cycler 480 SYBR Green Master (Roche; Basel Switzerland).

The scientists reported that a particular molecule, called miR-375, is released by the very cells in the pancreas that produce insulin. These cells normally contain lots of miR-375, which helps to control cell growth. In T1D it is released into the bloodstream in large quantities as soon as the cells begin to die. Their results indicate that that plasma miR-375 levels do not discriminate between different forms of T2D, but may be used as an indicator of acute β-cell destruction and autoimmune diabetes.

The authors concluded that their findings are supported by higher miR-375 levels in the circulation of T1D subjects but not mature onset diabetes of the young (MODY) andT2D patients. Together, their data support an essential role for miR-375 in the maintenance of β-cell mass and provide in vivo evidence for release of miRNAs from pancreatic β-cells. The small contribution of β-cells to total plasma miR-375 levels make this miRNA an unlikely biomarker for β-cell function but suggests a utility for the detection of acute β-cell death for autoimmune diabetes. The study was published on May 28, 2015, in the Journal of Molecular Medicine.

Related Links:

Imperial College London 
Applied Biosystems 
Roche 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.